Quantel Medical Receives FDA Clearance for Ophthalmic Laser System

Quantel Medical has announced it has received FDA clearance for an ophthalmic laser system, according to a news release (pdf).

Advertisement

 

The SupraScan 577 laser is designed to treat retinal diseases. The company says the system combines 577nm yellow wavelength, pattern-scanning and MicroPulse tissue-sparing laser emission modes.

 

“We are proud to have passed this regulatory milestone,” said Jean-Marc Gendre, CEO of Quantel Medical, in the release. “Quantel was the first company in the world to bring to market a solid-state green retina laser in 1993, followed by a solid-state yellow retina laser in 2008. Today’s announcement of 510(k) clearance for the SupraScan 577, the most advanced solidstate yellow scanning retina laser allows Quantel USA to offer a market-changing solution to retina specialists in the United States.”

 

Quantel Medical is headquartered in France.

 

Related Articles on FDA Clearances:

Teleflex Receives FDA Clearance Vascular Access Catheter

Avinger Receives FDA Clearance for Optical Coherence Tomography Catheter

LDR Receives FDA Conditional Approval for Cervical Disc

Advertisement

Next Up in Ophthalmology

  • Southlake, Texas-based Retina Consultants of America has acquired Montana Retina Consultants, according to a Feb. 5 news release.  Bozeman-based Montana…

  • Vision Innovation Partners acquired Ophthalmic Associates of Alexandria (Va.), according to a Feb. 2 press release. Founded in 2010, Ophthalmic…

Advertisement

Comments are closed.